PTEN – clinical significance in colorectal cancer

Journal Title: OncoReview - Year 2016, Vol 6, Issue 2

Abstract

Phosphatase and tensin homolog deleted on chromosome ten (PTEN ) is a human suppressor gene. Its protein product is a bispecific phosphatase playing the complex role in the cell cycle regulating processes and apoptosis by the mechanism of signal transduction into the cell via tyrosine kinase B signaling pathway (PI3K/Akt/mTOR). Reduction or loss of PTEN function is implicated in the pathogenesis of many malignancies, including colorectal cancer. A gradual decrease in the function of PTEN in the sequence of transformations: normal tissue polyp–adenocarcinoma – disseminated cancer was indicated. The relation between the PTEN loss and the higher clinical severity of colorectal cancer was observed, i.a. higher TNM status and higher tendency to form metastases, leading in some of the studies to shortened patients survival during the observation period. The potential predictive value of the PTEN function loss for the EGFR-targeted therapy in patients with advanced colorectal cancer is the subject of controversy. The potential application of PTEN assessment in clinical practice as a prognostic and/or predictive factor requires further well designed prospective studies on larger patient population, using the unified methodology.The aim of the study is to summarize the current knowledge on the role of PTEN gene and PTEN protein in the pathogenesis of colorectal cancer and the role of PTEN in clinical practice.

Authors and Affiliations

Angelika Copija, Dariusz Waniczek, Katarzyna Walkiewicz, Łukasz Głogowski, Henryk Augustyniak, Ewa Nowakowska-Zajdel

Keywords

Related Articles

Everolimus in every day practice of metastatic renal cell carcinoma therapy – one center experience

Introduction: Everolimus is a selective mTOR inhibitor which received approval for treatment of advanced renal cell carcinoma (mRCC) after progression on or after treatment with VEGF-targeted therapy. The aim of this stu...

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Purpose: Somatostatin analogs are indicated for symptom control in patients with gastroenteropancreatic neuroendocrine tumors (NETs). The ability of somatostatin analogs to control the growth of well-differentiated metas...

Powikłania zakrzepowo-zatorowe podczas hormonoterapii raka piersi - opis przypadku

69-letnia otyła kobieta po przebytej mastektomii lewostronnej i operacji oszczędzającej prawej piersi z powodu raka piersi, po przebytej chemio- i radioterapii, w trakcie uzupełniającej hormonoterapii przy użyciu tamoksy...

Pazopanib - dilemmas in kidney cancer treatment

Progress in metastatic renal cell carcinoma treatment is generally based on new registered drugs. This brings improvement of results but it also needs the choice of proper drug. The decision is especially important in in...

Recurrent invasive pulmonary aspergillosis or breakthrough fungal infection in a child after haploidentical hematopoietic stem cell transplantation

Invasive fungal infections (IFI) are devastating and life threatening infections affecting especially immunocompromised patients. We report on a case of a 14-year-old boy with myelodysplastic syndrome (MDS), after haplo...

Download PDF file
  • EP ID EP78746
  • DOI 10.5604/20828691.1207995
  • Views 228
  • Downloads 0

How To Cite

Angelika Copija, Dariusz Waniczek, Katarzyna Walkiewicz, Łukasz Głogowski, Henryk Augustyniak, Ewa Nowakowska-Zajdel (2016). PTEN – clinical significance in colorectal cancer. OncoReview, 6(2), 86-90. https://www.europub.co.uk/articles/-A-78746